Form 4: Avanos Medical Former CEO Woody Joseph Fralin Reports Share Disposals for Tax Obligations

Sentiment:

SEC Form 4 Filing


Former Avanos Medical CEO, Woody Joseph Fralin, reports disposing of shares to cover tax obligations upon the vesting of restricted share units.

Summary

  • On March 6, 2025, former Avanos Medical CEO Woody Joseph Fralin disposed of 11,827 shares of common stock at $15.3 to cover tax obligations related to the vesting of 28,561 time-based restricted share units (TRSUs) awarded on March 6, 2023.
  • Additionally, Fralin disposed of 20,249 shares of common stock at $15.3 to cover tax obligations related to the vesting of 45,258 time-based restricted share units (TRSUs) awarded on March 6, 2024.
  • Following these transactions, Fralin beneficially owns 402,776 shares of Avanos Medical common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock transactions for tax purposes, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and does not necessarily reflect a change in the company's outlook or performance.

Stakeholder Impact

  • The share disposals may have a minor impact on shareholders due to the increased supply of shares, but the effect is likely minimal given the relatively small number of shares involved.

Key Dates

DateDescription
03/06/202328,561 time-based restricted share units (TRSUs) were awarded to the Reporting Person
03/06/202445,258 time-based restricted share units (TRSUs) were awarded to the Reporting Person
03/06/2025Date of share disposals and vesting of TRSUs.
03/10/2025Date of signature by attorney-in-fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.